Qiagen reported after the close of the market on Tuesday that its fourth quarter revenues grew 2 percent year over year, beating previous guidance and analyst estimates on the top and bottom line.

Calibre Scientific said on Tuesday that it has acquired French life science reagent and instrument distributor AmpliTech.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho

On December 14, Beijing Hotgen Biotech Co., Ltd. announced that the company intends to acquire 38.0993% equity interest in Oriomics by way of equity transfer and subscription of additional registered capital at a price of CNY 153 million.

Since December 2019, the epidemic has raged all over the world. Affected by the epidemic, more than 1,400 China in vitro diagnostic companies are facing severe challenges. As of the end of November, 24 IVD-related companies have been successfully listed during the epidemic.

On November 15, 2021, Vazyme Biotech Co., Ltd. (hereinafter referred to as "Vazyme") was listed on SSE STAR Market. Stock abbreviation: Vazyme, stock code: 688105. The issue price is 55 yuan/share, and the opening price is 74 yuan/share.

CareDx reported after the close of the market on Thursday that its third quarter revenues rose 42 percent year over year, thanks largely to a 46 percent increase in testing service revenues during the quarter.

Thermo Fisher Scientific reported before the opening of the market on Wednesday that its third quarter revenues rose 9 percent year over year, thanks to growth across three of its four business segments.

Lucid Diagnostics on Thursday announced a proposed initial public offering of its common stock.

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a merger with Artisan Acquisition, a special purpose acquisition company. According to the Wall Street Journal, the deal values the company at $1.25 billion.